Skip to main content
Erschienen in: Comparative Clinical Pathology 4/2007

01.11.2007 | Original Article

Acute bone marrow stromal injury in the dog

verfasst von: Douglas J. Weiss

Erschienen in: Comparative Clinical Pathology | Ausgabe 4/2007

Einloggen, um Zugang zu erhalten

Abstract

A 5-year retrospective study of bone marrow reports was conducted to identify dogs with acute marrow stromal injury. Of 382 reports that were included in the study, acute stromal alterations were identified in 27 (7.1%). Disease conditions associated with these inflammatory changes included nonregenerative immune-mediated hemolytic anemia (IMA), systemic lupus erythematosus, immune-mediated thrombocytopenia, infectious diseases, drug treatments, and idiopathic conditions. Pathologic changes associated with acute stromal injury included coagulation-type necrosis, individual cell necrosis, dilated sinusoids, interstitial edema, hemorrhage, multifocal fibrin deposits, and multifocal neutrophilic infiltrates. Nonregenerative IMA tended to be associated with individual cell necrosis and evidence of vascular injury and acute inflammation. Infectious diseases tended to be associated with coagulation-type necrosis vascular injury and acute inflammation. Microabscesses were observed only in dogs with bacterial infections. Acute stromal injury associated with drug treatments were associated with coagulation-type necrosis but not with vascular injury or acute inflammation. The pattern of these changes may be useful in suggesting possible causes.
Literatur
Zurück zum Zitat Bain BJ, Clark DM, Lampert IA et al (2001) Infection and reactive changes. In: Bain BJ, Clark DM, Lampert IA et al (eds) Bone marrow pathology. Blackwell Science, Ames, IA, pp 90–138 Bain BJ, Clark DM, Lampert IA et al (2001) Infection and reactive changes. In: Bain BJ, Clark DM, Lampert IA et al (eds) Bone marrow pathology. Blackwell Science, Ames, IA, pp 90–138
Zurück zum Zitat Carr AP, Panciera DL, Kidd L (2002) Prognostic factors for mortality and thromboembolism in canine immune-mediated hemolytic anemia: a retrospective study of 72 dogs. J Vet Intern Med 16:504–509PubMedCrossRef Carr AP, Panciera DL, Kidd L (2002) Prognostic factors for mortality and thromboembolism in canine immune-mediated hemolytic anemia: a retrospective study of 72 dogs. J Vet Intern Med 16:504–509PubMedCrossRef
Zurück zum Zitat Dalm J, Schultze AE, Roth RA (1991) Activated neutrophil injury to the isolated perfused rat liver by an oxygen radical-dependent mechanism. Am J Pathol 139:1009–1020 Dalm J, Schultze AE, Roth RA (1991) Activated neutrophil injury to the isolated perfused rat liver by an oxygen radical-dependent mechanism. Am J Pathol 139:1009–1020
Zurück zum Zitat Dalmaso AP (1986) Complement in the pathophysiology and diagnosis of human diseases. CRC Crit Rev Clin Lab Sci 24:123–183 Dalmaso AP (1986) Complement in the pathophysiology and diagnosis of human diseases. CRC Crit Rev Clin Lab Sci 24:123–183
Zurück zum Zitat Frisch B, Lewis SM, Burkhardt R et al (1985) The cytopenias: non-haematopoietic components. In: Frisch B, Lewis SM, Burkhardt R et al (eds) Biopsy pathology of bone and bone marrow. Raven, Yew York, pp 58–70 Frisch B, Lewis SM, Burkhardt R et al (1985) The cytopenias: non-haematopoietic components. In: Frisch B, Lewis SM, Burkhardt R et al (eds) Biopsy pathology of bone and bone marrow. Raven, Yew York, pp 58–70
Zurück zum Zitat Hansson-Hamlin H, Lilliehook I, Trowald-Wigh G (2006) Subgroups of canine antinuclear antibodies in relation to laboratory and clinical findings in immune-mediated disease. Vet Clin Pathol 35:397–404PubMedCrossRef Hansson-Hamlin H, Lilliehook I, Trowald-Wigh G (2006) Subgroups of canine antinuclear antibodies in relation to laboratory and clinical findings in immune-mediated disease. Vet Clin Pathol 35:397–404PubMedCrossRef
Zurück zum Zitat Hoenig M (1989) Six dogs with features compatible with myelonecrosis and myelofibrosis. J Am Anim Hosp Assoc 25:335–339 Hoenig M (1989) Six dogs with features compatible with myelonecrosis and myelofibrosis. J Am Anim Hosp Assoc 25:335–339
Zurück zum Zitat Hoshi H, Weiss L (1978) Rabbit bone marrow after the administration of saponin. Lab Invest 38:67–80PubMed Hoshi H, Weiss L (1978) Rabbit bone marrow after the administration of saponin. Lab Invest 38:67–80PubMed
Zurück zum Zitat Schlag R, Burhardt R, Bartl R et al (1984) Acute and chronic inflammatory changes in the bone marrow. In: Lennertm K, Hubner K (eds) Pathology of the bone marrow. Gustav Fischer, New York, pp 411–416 Schlag R, Burhardt R, Bartl R et al (1984) Acute and chronic inflammatory changes in the bone marrow. In: Lennertm K, Hubner K (eds) Pathology of the bone marrow. Gustav Fischer, New York, pp 411–416
Zurück zum Zitat Thomason KJ, Feldman BF (1985) Immune-mediated thrombocytopenia: diagnosis and treatment. Comp Contin Educ Pract Vet 7:569–576 Thomason KJ, Feldman BF (1985) Immune-mediated thrombocytopenia: diagnosis and treatment. Comp Contin Educ Pract Vet 7:569–576
Zurück zum Zitat Weiss DJ (2005) Bone marrow necrosis in dogs: 34 cases (1996–2004). J Am Vet Med Assoc 227:263–267PubMedCrossRef Weiss DJ (2005) Bone marrow necrosis in dogs: 34 cases (1996–2004). J Am Vet Med Assoc 227:263–267PubMedCrossRef
Zurück zum Zitat Weiss DJ (2006) A retrospective study of the incidence and classification of bone marrow disorders in the dog at a veterinary teaching hospital (1996–2004). J Vet Intern Med 20:955–961PubMedCrossRef Weiss DJ (2006) A retrospective study of the incidence and classification of bone marrow disorders in the dog at a veterinary teaching hospital (1996–2004). J Vet Intern Med 20:955–961PubMedCrossRef
Zurück zum Zitat Weiss DJ, Armstrong PJ, Reimann K (1985) Bone marrow necrosis in the dog. J Am Vet Med Assoc 187:54–59PubMed Weiss DJ, Armstrong PJ, Reimann K (1985) Bone marrow necrosis in the dog. J Am Vet Med Assoc 187:54–59PubMed
Zurück zum Zitat Weiss DJ, Greig B, Aird B et al (1992) Inflammatory disorders of bone marrow. Vet Clin Pathol 21:79–84PubMedCrossRef Weiss DJ, Greig B, Aird B et al (1992) Inflammatory disorders of bone marrow. Vet Clin Pathol 21:79–84PubMedCrossRef
Zurück zum Zitat Weiss DJ, Welle M, Moritz A et al (2004) Evaluation of leukocyte cell surface markers in dogs with septic and nonseptic inflammatory diseases. Am J Vet Res 65:59–63PubMedCrossRef Weiss DJ, Welle M, Moritz A et al (2004) Evaluation of leukocyte cell surface markers in dogs with septic and nonseptic inflammatory diseases. Am J Vet Res 65:59–63PubMedCrossRef
Zurück zum Zitat Yoshida M, Hirata M, Hatano Y (1970) Hemorrhagic necrosis in the bone marrow caused by endotoxin injection. Jpn J Med Sci Biol 23:367–372PubMed Yoshida M, Hirata M, Hatano Y (1970) Hemorrhagic necrosis in the bone marrow caused by endotoxin injection. Jpn J Med Sci Biol 23:367–372PubMed
Metadaten
Titel
Acute bone marrow stromal injury in the dog
verfasst von
Douglas J. Weiss
Publikationsdatum
01.11.2007
Verlag
Springer-Verlag
Erschienen in
Comparative Clinical Pathology / Ausgabe 4/2007
Print ISSN: 1618-5641
Elektronische ISSN: 1618-565X
DOI
https://doi.org/10.1007/s00580-007-0698-7

Weitere Artikel der Ausgabe 4/2007

Comparative Clinical Pathology 4/2007 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …